Literature DB >> 12832069

Atypical properties displayed by annexin A9, a novel member of the annexin family of Ca(2+) and lipid binding proteins.

Verena Goebeler1, Daniela Ruhe, Volker Gerke, Ursula Rescher.   

Abstract

Annexin A9 is a novel member of the annexin family of Ca(2+) and phospholipid binding proteins which has so far only been identified in EST data bases and whose deduced protein sequence shows mutations in residues considered crucial for Ca(2+) coordination in other annexins. To elucidate whether the annexin A9 protein is expressed as such and to characterize its biochemical properties we probed cell extracts with specific anti-annexin A9 antibodies and developed a recombinant expression system. We show that the protein is found in HepG2 hepatoma cell lysates and that a green fluorescent protein-tagged form is abundantly expressed in the cytosol of HeLa cells. Recombinant expression in bacteria yields a soluble protein that can be enriched by conventional chromatographic procedures. The protein is capable of binding phosphatidylserine containing liposomes albeit only at Ca(2+) concentrations exceeding 2 mM. Moreover and in contrast to other annexins this binding appears to be irreversible as the liposome-bound annexin A9 cannot be released by Ca(2+) chelation. These results indicate that annexin A9 is a unique member of the annexin family whose intracellular activity is not subject to Ca(2+) regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832069     DOI: 10.1016/s0014-5793(03)00634-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  Annexin Animal Models-From Fundamental Principles to Translational Research.

Authors:  Thomas Grewal; Carles Rentero; Carlos Enrich; Mohamed Wahba; Carsten A Raabe; Ursula Rescher
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

2.  Selective ablation of the androgen receptor in mouse sertoli cells affects sertoli cell maturation, barrier formation and cytoskeletal development.

Authors:  Ariane Willems; Sergio R Batlouni; Arantza Esnal; Johannes V Swinnen; Philippa T K Saunders; Richard M Sharpe; Luiz R França; Karel De Gendt; Guido Verhoeven
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

3.  The tumor suppressor annexin A10 is a novel component of nuclear paraspeckles.

Authors:  Nina Quiskamp; Michaela Poeter; Carsten Alexander Raabe; Ulli Martin Hohenester; Simone König; Volker Gerke; Ursula Rescher
Journal:  Cell Mol Life Sci       Date:  2013-05-29       Impact factor: 9.261

4.  Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9.

Authors:  Xinxin Kou; Hui Ding; Lei Li; Hongtu Chao
Journal:  Anal Cell Pathol (Amst)       Date:  2021-02-24       Impact factor: 2.916

5.  ANXA9 as a novel prognostic biomarker associated with immune infiltrates in gastric cancer.

Authors:  Tongtong Zhang; Suyang Yu; Shipeng Zhao
Journal:  PeerJ       Date:  2021-12-15       Impact factor: 2.984

Review 6.  Pathobiological functions and clinical implications of annexin dysregulation in human cancers.

Authors:  Llara Prieto-Fernández; Sofía T Menéndez; María Otero-Rosales; Irene Montoro-Jiménez; Francisco Hermida-Prado; Juana M García-Pedrero; Saúl Álvarez-Teijeiro
Journal:  Front Cell Dev Biol       Date:  2022-09-28

7.  Annexin-phospholipid interactions. Functional implications.

Authors:  María Antonia Lizarbe; Juan I Barrasa; Nieves Olmo; Francisco Gavilanes; Javier Turnay
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

8.  ANXA9 gene expression in colorectal cancer: A novel marker for prognosis.

Authors:  Norikatsu Miyoshi; Hirofumi Yamamoto; Koshi Mimori; Shinya Yamashita; Susumu Miyazaki; Sumiko Nakagawa; Hideshi Ishii; Shingo Noura; Masayuki Ohue; Masahiko Yano; Yuichiro Doki; Masaki Mori
Journal:  Oncol Lett       Date:  2014-08-25       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.